Preventing Acute Kidney Injury and Improving Outcome in Critically Ill Patients Utilising Risk Prediction Score
PRAIOC-RISKS
1 other identifier
interventional
198
1 country
1
Brief Summary
An interventional controlled trial to test the feasibility of applying risk score based prevention for critically ill patient at high risk to develop acute kidney injury (AKI)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 4, 2017
CompletedFirst Posted
Study publicly available on registry
June 7, 2017
CompletedStudy Start
First participant enrolled
September 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedFebruary 26, 2019
February 1, 2019
7 months
June 4, 2017
February 25, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of AKI
We will compare the incidence rate between the interventional and the observational arm
during 7 days of ICU admission
Secondary Outcomes (4)
30 day mortality
30 days
Time to recovery after development of AKI
30 days
Deterioration of AKI stage
30 days
Duration of dialysis dependency
30 days
Study Arms (2)
Observational
NO INTERVENTIONpatients will be recruited to this arm to observe prospectively the incidence of AKI among critically ill patients.patients will receive the standard care.No other intervention will be delivered
Interventional
ACTIVE COMPARATORPatients in this arm will be subject to AKI risk score. This risk score was recently developed and validated in Mayo clinic the intervention will be Measures to prevent AKI among critically ill patients
Interventions
1. Meticulous optimization of the fluid balance 2. Avoidance of nephrotoxic medications where possible 3. Optimisation of the hemodynamic status 4. Avoidance of blood transfusion unless marked acute blood loss or symptomatic anemia 5. Optimization of the underlying medical condition 6. Seek expert renal advise when necessary
Eligibility Criteria
You may qualify if:
- All adult patients (≥18 year old) admitted to the intensive care unit and do not fulfill the criteria for the diagnosis of AKI by Kidney Disease Improving Global Outcome (KDIGO) definition
You may not qualify if:
- Patients who have already developed AKI at the time of intensive care unit ICU admission.
- Patients with insufficient medical records to obtain previous medical history
- Patients who lack mental capacity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cairo university hospitals
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior lecturer
Study Record Dates
First Submitted
June 4, 2017
First Posted
June 7, 2017
Study Start
September 1, 2017
Primary Completion
April 1, 2018
Study Completion
September 1, 2018
Last Updated
February 26, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share